Return to Directory Key Opinion Leaders in Clinical Trials Areas - word selected:- NEUROFIBROMATOSIS
Names, CVs (as available), locations and contact details of Investigators are available to Subscribers.
To subscribe, please contact Emma Taylor at emma@specialistinfo.com or 01423 727 724 for details on subscription costs.
Page No 1
PhraseConsultantTownSpecial Interests
neurofibromatosis
*Consultant(s)*
*Towns*Splicing mutations in disease, neurofibromatosis, dysmorphology, eye genetics
neurofibromatosis
*Consultant(s)*
*Towns*Colorectal cancer research, cancer epidemiology, hereditary cancer and cancer syndromes, breast cancer research, neurofibromatosis
neurofibromatosis
*Consultant(s)*
*Towns*Neurogenetics, motor neurone disease, neurofibromatosis, ataxia telangiectasia
neurofibromatosis
*Consultant(s)*
*Towns*Complex spinal disease, pituitary tumours, acoustic neuroma, neurofibromatosis, endoscopic skull base surgery
neurofibromatosis type 1 and 2
*Consultant(s)*
*Towns*General/adult clinical genetics, cancer genetics, neurofibromatosis type 1 and 2, Marfan's syndrome
neurofibromatosis type 2
*Consultant(s)*
*Towns*Skull base neurosurgery, acoustic neuroma, degenerative spinal surgery, neurofibromatosis type 2, trigeminal neuralgia
Page No 1
Spacer

Third Party Advertisement

Adverts by Google